Sarepta Therapeutics, Inc.
SRPT • NASDAQ • Stock Fundamentals
Sarepta Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Douglas S. Ingram, with a market cap of $1.6B.
Market Cap$1.6B
Employees1.3K
CEODouglas S. Ingram
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Sarepta Therapeutics, Inc. FAQ
Common questions about Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. (SRPT) has a market capitalization of $1.6B and trades on NASDAQ.
Sarepta Therapeutics, Inc. has approximately 1,314 employees.